Search results
Pleasing Signs As A Number Of Insiders Buy Aprea Therapeutics Stock
Simply Wall St. via Yahoo Finance· 2 hours agoUsually, when one insider buys stock, it might not be a monumental event. But when multiple insiders...
Viridian Therapeutics (NASDAQ:VRDN) Earns Outperform Rating from Analysts at Wolfe Research
ETF DAILY NEWS· 6 hours agoInvestment analysts at Wolfe Research started coverage on shares of Viridian Therapeutics (NASDAQ:VRDN – Get Free Report) in a note issued to investors on Tuesday, Briefing.com ...
Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time...
Motley Fool via Yahoo Finance· 5 hours agoShares of Structure Therapeutics (NASDAQ: GPCR) shot up more than 50% during the first week of June....
Brokerages Set Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Target Price at $64.86
ETF DAILY NEWS· 11 hours agoArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven research firms that are covering the ...
Fate Therapeutics, Inc. (NASDAQ:FATE) Given Average Recommendation of “Hold” by Analysts
ETF DAILY NEWS· 12 hours agoFate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) has earned a consensus recommendation of “Hold” from the fourteen analysts that are presently covering the firm, MarketBeat ...
Enliven Therapeutics, Inc. (NASDAQ:ELVN) COO Anish Patel Sells 1,133 Shares
ETF DAILY NEWS· 8 hours agoEnliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) COO Anish Patel sold 1,133 shares of the firm’s stock in a transaction dated Thursday, June 6th. The stock was sold ...
Invenomic Capital Management LP Buys 116,679 Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK)
ETF DAILY NEWS· 4 hours agoInvenomic Capital Management LP grew its stake in shares of Anika Therapeutics, Inc. (NASDAQ:ANIK – Free Report) by 124.6% during the 4th quarter, according to the company ...
Skyhawk Therapeutics Promotes Clint Musil to Chief Executive Officer and Appoints Co-founder Bill...
Benzinga· 1 hour agoSkyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA targets, today announced the ...
Here’s Why Viking Therapeutics (VKTX) Shares Rose in Q1
Insider Monkey via Yahoo Finance· 3 hours agoBaron Funds, an investment management company, released its “Baron Opportunity Fund” first quarter...
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals | The Motley Fool
The Motley Fool· 24 hours agoViking Therapeutics (VKTX 0.70%) and Madrigal Pharmaceuticals (MDGL 4.31%) are highly prominent...